Annual CFO
-$40.20 M
+$8.53 M+17.51%
December 31, 2023
Summary
- As of February 8, 2025, AXDX annual cash flow from operations is -$40.20 million, with the most recent change of +$8.53 million (+17.51%) on December 31, 2023.
- During the last 3 years, AXDX annual CFO has risen by +$10.20 million (+20.24%).
- AXDX annual CFO is now -1186.38% below its all-time high of $3.70 million, reached on July 31, 1998.
Performance
AXDX Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$3.09 M
+$4.49 M+59.24%
September 30, 2024
Summary
- As of February 8, 2025, AXDX quarterly cash flow from operations is -$3.09 million, with the most recent change of +$4.49 million (+59.24%) on September 30, 2024.
- Over the past year, AXDX quarterly CFO has stayed the same.
- AXDX quarterly CFO is now -339.39% below its all-time high of $1.29 million, reached on April 30, 1998.
Performance
AXDX Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$26.88 M
+$5.16 M+16.11%
September 30, 2024
Summary
- As of February 8, 2025, AXDX TTM cash flow from operations is -$26.88 million, with the most recent change of +$5.16 million (+16.11%) on September 30, 2024.
- Over the past year, AXDX TTM CFO has stayed the same.
- AXDX TTM CFO is now -795.93% below its all-time high of $3.86 million, reached on October 31, 1998.
Performance
AXDX TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
AXDX Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +17.5% | 0.0% | 0.0% |
| 3 y3 years | +20.2% | 0.0% | 0.0% |
| 5 y5 years | +40.7% | 0.0% | 0.0% |
AXDX Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +17.5% | at high | +77.2% | at high | +47.4% |
| 5 y | 5-year | at high | +38.0% | at high | +82.4% | at high | +58.5% |
| alltime | all time | -1186.4% | +40.7% | -339.4% | +84.2% | -795.9% | +62.2% |
Accelerate Diagnostics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$3.09 M(-59.2%) | -$26.88 M(-16.1%) |
| Jun 2024 | - | -$7.58 M(-10.3%) | -$32.04 M(-9.2%) |
| Mar 2024 | - | -$8.45 M(+9.0%) | -$35.28 M(-12.2%) |
| Dec 2023 | -$40.20 M(-17.5%) | -$7.75 M(-6.0%) | -$40.20 M(-4.3%) |
| Sep 2023 | - | -$8.25 M(-23.7%) | -$41.99 M(-11.2%) |
| Jun 2023 | - | -$10.82 M(-19.0%) | -$47.31 M(-4.4%) |
| Mar 2023 | - | -$13.37 M(+40.0%) | -$49.49 M(+1.6%) |
| Dec 2022 | -$48.73 M(+3.0%) | -$9.55 M(-29.6%) | -$48.73 M(-4.7%) |
| Sep 2022 | - | -$13.57 M(+4.4%) | -$51.13 M(+2.3%) |
| Jun 2022 | - | -$13.00 M(+3.1%) | -$50.00 M(+7.4%) |
| Mar 2022 | - | -$12.61 M(+5.5%) | -$46.55 M(-1.6%) |
| Dec 2021 | -$47.32 M(-6.1%) | -$11.95 M(-4.0%) | -$47.32 M(+3.5%) |
| Sep 2021 | - | -$12.45 M(+30.3%) | -$45.72 M(-0.5%) |
| Jun 2021 | - | -$9.55 M(-28.6%) | -$45.93 M(-0.5%) |
| Mar 2021 | - | -$13.38 M(+29.3%) | -$46.17 M(-8.4%) |
| Dec 2020 | -$50.39 M(-22.2%) | -$10.34 M(-18.3%) | -$50.39 M(-6.5%) |
| Sep 2020 | - | -$12.66 M(+29.2%) | -$53.92 M(-8.0%) |
| Jun 2020 | - | -$9.80 M(-44.3%) | -$58.63 M(-6.8%) |
| Mar 2020 | - | -$17.60 M(+26.9%) | -$62.89 M(-2.9%) |
| Dec 2019 | -$64.79 M(-4.4%) | -$13.87 M(-20.2%) | -$64.79 M(-0.7%) |
| Sep 2019 | - | -$17.37 M(+23.5%) | -$65.25 M(-1.0%) |
| Jun 2019 | - | -$14.06 M(-27.9%) | -$65.90 M(-7.4%) |
| Mar 2019 | - | -$19.50 M(+36.2%) | -$71.19 M(+5.1%) |
| Dec 2018 | -$67.76 M(+21.5%) | -$14.33 M(-20.5%) | -$67.76 M(+1.6%) |
| Sep 2018 | - | -$18.01 M(-6.9%) | -$66.68 M(+5.7%) |
| Jun 2018 | - | -$19.35 M(+20.4%) | -$63.07 M(+11.9%) |
| Mar 2018 | - | -$16.07 M(+21.3%) | -$56.34 M(+1.1%) |
| Dec 2017 | -$55.75 M(+4.4%) | -$13.25 M(-8.0%) | -$55.75 M(+0.8%) |
| Sep 2017 | - | -$14.41 M(+14.1%) | -$55.30 M(+3.5%) |
| Jun 2017 | - | -$12.62 M(-18.4%) | -$53.41 M(-4.1%) |
| Mar 2017 | - | -$15.47 M(+20.8%) | -$55.67 M(+4.2%) |
| Dec 2016 | -$53.41 M(+52.0%) | -$12.80 M(+2.2%) | -$53.41 M(+5.8%) |
| Sep 2016 | - | -$12.52 M(-15.9%) | -$50.49 M(+7.8%) |
| Jun 2016 | - | -$14.88 M(+12.7%) | -$46.86 M(+13.3%) |
| Mar 2016 | - | -$13.21 M(+33.6%) | -$41.37 M(+17.8%) |
| Dec 2015 | -$35.13 M(+87.0%) | -$9.89 M(+11.3%) | -$35.13 M(+17.0%) |
| Sep 2015 | - | -$8.88 M(-5.4%) | -$30.03 M(+9.9%) |
| Jun 2015 | - | -$9.39 M(+34.9%) | -$27.34 M(+23.8%) |
| Mar 2015 | - | -$6.96 M(+45.3%) | -$22.07 M(+17.5%) |
| Dec 2014 | -$18.79 M(+92.7%) | -$4.79 M(-22.6%) | -$18.79 M(+12.2%) |
| Sep 2014 | - | -$6.19 M(+49.8%) | -$16.74 M(+25.1%) |
| Jun 2014 | - | -$4.13 M(+12.5%) | -$13.38 M(+20.0%) |
| Mar 2014 | - | -$3.67 M(+33.7%) | -$11.15 M(+14.4%) |
| Dec 2013 | -$9.75 M(+356.4%) | -$2.75 M(-2.8%) | -$9.75 M(+39.2%) |
| Sep 2013 | - | -$2.83 M(+48.6%) | -$7.00 M(+32.9%) |
| Jun 2013 | - | -$1.90 M(-16.4%) | -$5.27 M(+40.4%) |
| Mar 2013 | - | -$2.27 M(+107.8%) | -$3.75 M(+107.3%) |
| Dec 2012 | -$2.14 M(+161.8%) | - | - |
| Oct 2012 | - | -$1.09 M(+184.7%) | -$1.81 M(+121.9%) |
| Jul 2012 | -$816.00 K(+341.1%) | -$384.30 K(+39.8%) | -$816.00 K(+320.0%) |
| Apr 2012 | - | -$274.90 K(+381.4%) | -$194.30 K(-461.2%) |
| Jan 2012 | - | -$57.10 K(-42.7%) | $53.80 K(-86.2%) |
| Dec 2011 | -$185.00 K(-141.2%) | - | - |
| Oct 2011 | - | -$99.70 K(-142.0%) | $390.80 K(-12.9%) |
| Jul 2011 | $448.50 K | $237.40 K(-985.8%) | $448.50 K(+31.3%) |
| Apr 2011 | - | -$26.80 K(-109.6%) | $341.70 K(+238.7%) |
| Jan 2011 | - | $279.90 K(-766.4%) | $100.90 K(-119.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Oct 2010 | - | -$42.00 K(-132.2%) | -$529.40 K(-32.9%) |
| Jul 2010 | -$789.60 K(+249.8%) | $130.60 K(-148.8%) | -$789.50 K(-21.7%) |
| Apr 2010 | - | -$267.60 K(-23.6%) | -$1.01 M(+38.3%) |
| Jan 2010 | - | -$350.40 K(+16.0%) | -$729.60 K(+58.7%) |
| Oct 2009 | - | -$302.10 K(+240.6%) | -$459.70 K(+103.7%) |
| Jul 2009 | -$225.70 K(-76.6%) | -$88.70 K(-864.7%) | -$225.70 K(-16.3%) |
| Apr 2009 | - | $11.60 K(-114.4%) | -$269.80 K(-58.6%) |
| Jan 2009 | - | -$80.50 K(+18.2%) | -$651.40 K(-15.9%) |
| Oct 2008 | - | -$68.10 K(-48.7%) | -$774.70 K(-19.6%) |
| Jul 2008 | -$963.70 K(-37.2%) | -$132.80 K(-64.1%) | -$963.70 K(-22.2%) |
| Apr 2008 | - | -$370.00 K(+81.6%) | -$1.24 M(+5.9%) |
| Jan 2008 | - | -$203.80 K(-20.7%) | -$1.17 M(-16.5%) |
| Oct 2007 | - | -$257.10 K(-36.9%) | -$1.40 M(-8.8%) |
| Jul 2007 | -$1.54 M(-41.9%) | -$407.60 K(+35.6%) | -$1.54 M(-0.5%) |
| Apr 2007 | - | -$300.70 K(-30.8%) | -$1.54 M(-19.2%) |
| Jan 2007 | - | -$434.70 K(+10.7%) | -$1.91 M(-13.5%) |
| Oct 2006 | - | -$392.70 K(-5.5%) | -$2.21 M(-16.4%) |
| Jul 2006 | -$2.64 M(+65.1%) | -$415.60 K(-37.7%) | -$2.64 M(-1.5%) |
| Apr 2006 | - | -$667.00 K(-9.0%) | -$2.68 M(+8.4%) |
| Jan 2006 | - | -$733.00 K(-11.2%) | -$2.47 M(+18.3%) |
| Oct 2005 | - | -$825.30 K(+81.2%) | -$2.09 M(+30.7%) |
| Jul 2005 | -$1.60 M(+31.6%) | -$455.40 K(-0.8%) | -$1.60 M(+15.4%) |
| Apr 2005 | - | -$459.30 K(+30.9%) | -$1.39 M(+27.7%) |
| Jan 2005 | - | -$350.90 K(+5.1%) | -$1.09 M(-0.6%) |
| Oct 2004 | - | -$334.00 K(+38.0%) | -$1.09 M(-10.2%) |
| Jul 2004 | -$1.22 M(-903.8%) | -$242.00 K(+53.0%) | -$1.22 M(+25.1%) |
| Apr 2004 | - | -$158.20 K(-55.7%) | -$971.60 K(-26.0%) |
| Jan 2004 | - | -$357.10 K(-22.0%) | -$1.31 M(+226.1%) |
| Oct 2003 | - | -$458.10 K(<-9900.0%) | -$402.50 K(-366.2%) |
| Jul 2003 | $151.20 K(-122.7%) | $1800.00(-100.4%) | $151.20 K(-29.2%) |
| Apr 2003 | - | -$499.10 K(-190.3%) | $213.50 K(-67.5%) |
| Jan 2003 | - | $552.90 K(+478.3%) | $657.30 K(-388.2%) |
| Oct 2002 | - | $95.60 K(+49.1%) | -$228.10 K(-65.7%) |
| Jul 2002 | -$665.20 K(+944.3%) | $64.10 K(-215.9%) | -$665.10 K(-30.8%) |
| Apr 2002 | - | -$55.30 K(-83.4%) | -$961.00 K(-14.5%) |
| Jan 2002 | - | -$332.50 K(-2.6%) | -$1.12 M(+121.7%) |
| Oct 2001 | - | -$341.40 K(+47.3%) | -$507.00 K(+694.7%) |
| Jul 2001 | -$63.70 K(-115.5%) | -$231.80 K(+6.1%) | -$63.80 K(+67.9%) |
| Apr 2001 | - | -$218.50 K(-176.7%) | -$38.00 K(-73.0%) |
| Jan 2001 | - | $284.70 K(+179.7%) | -$140.60 K(+1774.7%) |
| Oct 2000 | - | $101.80 K(-149.4%) | -$7500.00(-101.8%) |
| Jul 2000 | $410.60 K(-60.5%) | -$206.00 K(-35.8%) | $410.60 K(-45.6%) |
| Apr 2000 | - | -$321.10 K(-176.9%) | $754.90 K(-46.9%) |
| Jan 2000 | - | $417.80 K(-19.6%) | $1.42 M(+56.6%) |
| Oct 1999 | - | $519.90 K(+275.9%) | $907.40 K(-12.6%) |
| Jul 1999 | $1.04 M(-71.9%) | $138.30 K(-59.9%) | $1.04 M(-38.9%) |
| Apr 1999 | - | $344.60 K(-461.2%) | $1.70 M(-35.8%) |
| Jan 1999 | - | -$95.40 K(-114.7%) | $2.65 M(-31.5%) |
| Oct 1998 | - | $650.80 K(-18.6%) | $3.86 M(+4.4%) |
| Jul 1998 | $3.70 M(+311.1%) | $800.00 K(-38.0%) | $3.70 M(+12.1%) |
| Apr 1998 | - | $1.29 M(+15.2%) | $3.30 M(+64.3%) |
| Jan 1998 | - | $1.12 M(+129.5%) | $2.01 M(+84.6%) |
| Oct 1997 | - | $488.20 K(+22.1%) | $1.09 M(+20.9%) |
| Jul 1997 | $900.00 K(-18.2%) | $400.00 K(>+9900.0%) | $900.00 K(+80.0%) |
| Apr 1997 | - | $0.00(-100.0%) | $500.00 K(0.0%) |
| Jan 1997 | - | $200.00 K(-33.3%) | $500.00 K(+66.7%) |
| Oct 1996 | - | $300.00 K | $300.00 K |
| Jul 1996 | $1.10 M | - | - |
FAQ
- What is Accelerate Diagnostics annual cash flow from operations?
- What is the all time high annual CFO for Accelerate Diagnostics?
- What is Accelerate Diagnostics annual CFO year-on-year change?
- What is Accelerate Diagnostics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Accelerate Diagnostics?
- What is Accelerate Diagnostics quarterly CFO year-on-year change?
- What is Accelerate Diagnostics TTM cash flow from operations?
- What is the all time high TTM CFO for Accelerate Diagnostics?
- What is Accelerate Diagnostics TTM CFO year-on-year change?
What is Accelerate Diagnostics annual cash flow from operations?
The current annual CFO of AXDX is -$40.20 M
What is the all time high annual CFO for Accelerate Diagnostics?
Accelerate Diagnostics all-time high annual cash flow from operations is $3.70 M
What is Accelerate Diagnostics annual CFO year-on-year change?
Over the past year, AXDX annual cash flow from operations has changed by +$8.53 M (+17.51%)
What is Accelerate Diagnostics quarterly cash flow from operations?
The current quarterly CFO of AXDX is -$3.09 M
What is the all time high quarterly CFO for Accelerate Diagnostics?
Accelerate Diagnostics all-time high quarterly cash flow from operations is $1.29 M
What is Accelerate Diagnostics quarterly CFO year-on-year change?
Over the past year, AXDX quarterly cash flow from operations has changed by $0.00 (0.00%)
What is Accelerate Diagnostics TTM cash flow from operations?
The current TTM CFO of AXDX is -$26.88 M
What is the all time high TTM CFO for Accelerate Diagnostics?
Accelerate Diagnostics all-time high TTM cash flow from operations is $3.86 M
What is Accelerate Diagnostics TTM CFO year-on-year change?
Over the past year, AXDX TTM cash flow from operations has changed by $0.00 (0.00%)